Virus de l'immunodéficience simienne : Questions médicales fréquentes
Nom anglais: Simian Immunodeficiency Virus
Descriptor UI:D015302
Tree Number:B04.820.650.805.700
Termes MeSH sélectionnés :
Staphylococcus aureus
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus de l'immunodéficience simienne : Questions médicales les plus fréquentes",
"headline": "Virus de l'immunodéficience simienne : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus de l'immunodéficience simienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-04",
"dateModified": "2025-03-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus de l'immunodéficience simienne"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Rétrovirus simiens",
"url": "https://questionsmedicales.fr/mesh/D015301",
"about": {
"@type": "MedicalCondition",
"name": "Rétrovirus simiens",
"code": {
"@type": "MedicalCode",
"code": "D015301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.650.805"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus de l'immunodéficience simienne",
"alternateName": "Simian Immunodeficiency Virus",
"code": {
"@type": "MedicalCode",
"code": "D015302",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Woong-Ki Kim",
"url": "https://questionsmedicales.fr/author/Woong-Ki%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA."
}
},
{
"@type": "Person",
"name": "Hui Li",
"url": "https://questionsmedicales.fr/author/Hui%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA."
}
},
{
"@type": "Person",
"name": "Katharine J Bar",
"url": "https://questionsmedicales.fr/author/Katharine%20J%20Bar",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA bark@pennmedicine.upenn.edu."
}
},
{
"@type": "Person",
"name": "Bapi Pahar",
"url": "https://questionsmedicales.fr/author/Bapi%20Pahar",
"affiliation": {
"@type": "Organization",
"name": "Division of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United States."
}
},
{
"@type": "Person",
"name": "Arpita Das",
"url": "https://questionsmedicales.fr/author/Arpita%20Das",
"affiliation": {
"@type": "Organization",
"name": "Division of Microbiology, Tulane National Primate Research Center, Covington, LA, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Coordination of CcpA and CodY Regulators in Staphylococcus aureus USA300 Strains.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36321827",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/msystems.00480-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Acute paronychia in a neonate secondary to clindamycin-resistant Staphylococcus aureus.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36047838",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/pde.15017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections.",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/35973315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.diagmicrobio.2022.115772"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genomic alterations involved in fluoroquinolone resistance development in Staphylococcus aureus.",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37494330",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0287973"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fucoxanthin Potentiates the Bactericidal Activity of Cefotaxime Against Staphylococcus aureus.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37365295",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00284-023-03381-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Retroviridae",
"item": "https://questionsmedicales.fr/mesh/D012190"
},
{
"@type": "ListItem",
"position": 5,
"name": "Rétrovirus simiens",
"item": "https://questionsmedicales.fr/mesh/D015301"
},
{
"@type": "ListItem",
"position": 6,
"name": "Virus de l'immunodéficience simienne",
"item": "https://questionsmedicales.fr/mesh/D015302"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus de l'immunodéficience simienne - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus de l'immunodéficience simienne",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus de l'immunodéficience simienne",
"description": "Comment diagnostiquer une infection par le SIV ?\nQuels tests sont utilisés pour le SIV ?\nLe SIV peut-il être confondu avec le VIH ?\nQuels sont les signes cliniques du SIV ?\nLe SIV est-il transmissible à l'homme ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Staphylococcus+aureus&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus de l'immunodéficience simienne",
"description": "Quels sont les symptômes du SIV chez les singes ?\nLe SIV provoque-t-il des symptômes immédiats ?\nComment le SIV affecte-t-il le système immunitaire ?\nY a-t-il des symptômes spécifiques au SIV ?\nLe SIV peut-il être asymptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Staphylococcus+aureus&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus de l'immunodéficience simienne",
"description": "Comment prévenir l'infection par le SIV ?\nLe SIV peut-il être transmis par voie sexuelle ?\nY a-t-il des mesures de prévention pour les chercheurs ?\nLes tests réguliers sont-ils recommandés ?\nLes animaux de compagnie peuvent-ils transmettre le SIV ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Staphylococcus+aureus&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus de l'immunodéficience simienne",
"description": "Quel est le traitement du SIV chez les primates ?\nLes antirétroviraux sont-ils efficaces contre le SIV ?\nLe SIV nécessite-t-il une hospitalisation ?\nY a-t-il des vaccins contre le SIV ?\nComment gérer les infections opportunistes liées au SIV ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Staphylococcus+aureus&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus de l'immunodéficience simienne",
"description": "Quelles sont les complications du SIV ?\nLe SIV peut-il entraîner des cancers ?\nComment le SIV affecte-t-il la reproduction ?\nLe SIV peut-il causer des troubles neurologiques ?\nY a-t-il des effets à long terme du SIV ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Staphylococcus+aureus&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus de l'immunodéficience simienne",
"description": "Quels sont les facteurs de risque du SIV ?\nLes personnes vivant avec des animaux sauvages sont-elles à risque ?\nLes chercheurs en primatologie sont-ils exposés au SIV ?\nLe SIV est-il plus fréquent chez certains primates ?\nLes voyages dans des zones endommagées augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015302?mesh_terms=Staphylococcus+aureus&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le SIV ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sérologiques détectant des anticorps anti-SIV."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le SIV ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et PCR sont couramment utilisés pour détecter le SIV."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il être confondu avec le VIH ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes et les tests peuvent être similaires, nécessitant des tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques du SIV ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, perte de poids et infections opportunistes."
}
},
{
"@type": "Question",
"name": "Le SIV est-il transmissible à l'homme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SIV peut être transmis à l'homme, provoquant des infections similaires au VIH."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du SIV chez les singes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée, perte de poids et immunodéficience progressive."
}
},
{
"@type": "Question",
"name": "Le SIV provoque-t-il des symptômes immédiats ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes peuvent prendre des années à se manifester après l'infection."
}
},
{
"@type": "Question",
"name": "Comment le SIV affecte-t-il le système immunitaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le SIV cible les lymphocytes T, entraînant une diminution de la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques au SIV ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes spécifiques incluent des infections récurrentes et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il être asymptomatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains animaux peuvent être porteurs du SIV sans montrer de symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le SIV ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec des primates infectés et pratiquer une bonne hygiène."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il être transmis par voie sexuelle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SIV peut être transmis par contact sexuel avec des primates infectés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures de prévention pour les chercheurs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation d'équipements de protection individuelle est essentielle."
}
},
{
"@type": "Question",
"name": "Les tests réguliers sont-ils recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests réguliers peuvent aider à détecter une infection précoce."
}
},
{
"@type": "Question",
"name": "Les animaux de compagnie peuvent-ils transmettre le SIV ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, le SIV ne se transmet pas des animaux de compagnie aux humains."
}
},
{
"@type": "Question",
"name": "Quel est le traitement du SIV chez les primates ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique, mais des soins de soutien sont recommandés."
}
},
{
"@type": "Question",
"name": "Les antirétroviraux sont-ils efficaces contre le SIV ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antirétroviraux peuvent aider à contrôler l'infection chez les primates."
}
},
{
"@type": "Question",
"name": "Le SIV nécessite-t-il une hospitalisation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, mais une surveillance médicale est recommandée pour les cas graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins contre le SIV ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé contre le SIV."
}
},
{
"@type": "Question",
"name": "Comment gérer les infections opportunistes liées au SIV ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement des infections opportunistes est essentiel pour améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du SIV ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections opportunistes et des troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il entraîner des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'immunodéficience peut augmenter le risque de certains cancers chez les primates."
}
},
{
"@type": "Question",
"name": "Comment le SIV affecte-t-il la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le SIV peut entraîner des problèmes de fertilité et des complications pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Le SIV peut-il causer des troubles neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en raison de l'infection chronique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme du SIV ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme incluent une immunodéficience persistante et des maladies associées."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du SIV ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le contact avec des primates infectés et des pratiques sexuelles à risque."
}
},
{
"@type": "Question",
"name": "Les personnes vivant avec des animaux sauvages sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec des animaux sauvages peut augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les chercheurs en primatologie sont-ils exposés au SIV ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont à risque en raison de leur travail avec des primates potentiellement infectés."
}
},
{
"@type": "Question",
"name": "Le SIV est-il plus fréquent chez certains primates ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines espèces de singes sont plus susceptibles d'être infectées par le SIV."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones endommagées augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où le SIV est présent peut augmenter le risque d'exposition."
}
}
]
}
]
}
The complex cross talk between metabolism and gene regulatory networks makes it difficult to untangle individual constituents and study their precise roles and interactions. To address this issue, we ...
Paronychia is a common inflammatory condition of the nail fold that is often associated with infection. Causes can be fungal, viral, or most commonly, bacterial. Neonatal paronychia is a rare presenta...
The objective of this study was to examine the occurrence, determinants, and outcome of S. aureus bloodstream infections (BSI) diagnosed based on single versus multiple positive initial cultures....
All adults with first episodes of mono-microbial S. aureus BSI in Queensland during 2000-2019 were included....
10,855 (67%) and 5,421 (33%) were diagnosed based on one and multiple positive initial cultures, respectively. Patients with multiple positive initial cultures were significantly younger, more likely ...
Among patients with S. aureus BSI, those diagnosed by single positive initial blood cultures have different clinical features and a higher risk for death....
Fluoroquinolone (FQ) is a potent antibiotic class. However, resistance to this class emerges quickly which hinders its application. In this study, mechanisms leading to the emergence of multidrug-resi...
S. aureus ATCC 29213 was serially exposed to ciprofloxacin (CIP), ofloxacin (OFL), or levofloxacin (LEV) at sub-minimum inhibitory concentrations (sub-MICs) for 12 days to obtain S. aureus -1 strains ...
A strong and irreversible increase of MICs was observed in all applied FQs (32 to 128 times) in all S. aureus-1 and remained 16 to 32 times in all S. aureus-2. WGS indicated 10 noticeable mutations oc...
The emergence of MDR S. aureus was associated with the mutations in the FQ-target sequences and the overexpression of efflux pump systems and their regulators....
The increasing prevalence of antimicrobial resistance (AMR) in Staphylococcus aureus against commonly used antibiotics is a major global health issue. To prevent the emergence of AMR and maintain the ...
To perform natural transformation, one of the three main Horizontal Gene Transfer mechanisms, bacteria need to enter a physiological differentiated state called genetic competence. Interestingly, new ...
Platelets are recognized as key immune effectors, but they are targets of bacterial virulence factors. In the present study, we aimed to examine the relationship between early platelet dynamics and th...
Electronic medical records of adult patients hospitalized for SAB between July 2012 and November 2020 were retrospectively reviewed for relevant demographic, laboratory, and clinical data. The outcome...
Among the 811 patients evaluated, 29% experienced thrombocytopenia on Day 1. Platelet count nadir occurred on Days 2-3 following SAB onset, and Day 4 was a determining point of platelet count trajecto...
Early platelet dynamics during SAB have prognostic significance and represent an early window for potential platelet-directed therapeutic interventions to improve outcome....
The aim was to compare the incidence of Staphylococcus aureus bacteremia in COVID-19 and non-COVID-19 adult patients during the pandemic period versus the previous two years. Also, we described the ch...
Retrospective study in our tertiary-care centre reviewing S. aureus bacteremia episodes in COVID-19 and non-COVID-19 patients through clinical records and the Microbiology Department database....
In 2018 and 2019, the incidence of S. aureus bacteremia episodes was 1.95 and 1.63 per 1000 admissions respectively. In the pandemic period, global incidence was 1.96 episodes per 1000 non-COVID-19 ad...
We showed a significantly high rates of S. aureus bacteremia incidence in COVID-19 patients and higher methicillin resistance and 15-day mortality rates than in non-COVID-19 patients....
The primary host response to Staphylococcus aureus infection occurs via complement. Complement is an elegant evolutionarily conserved system, playing essential roles in early defences by working in co...
Retrospective cohort study....
The aim was to compare the influence of 2 common vertebral osteomyelitis (VO) causing pathogens on treatment failure within the first year of diagnosis....
VO is mainly caused by Staphylococcus aureus (SA), while enterococci and streptococci (ENST) are also responsible for a significant proportion of VO, particularly in elderly patients. Data on VO cause...
We conducted a retrospective monocentric study including VO patients from 2008 to 2020. Primary outcome was treatment failure defined as death or relapse within 1 year (T1). We compared patients diagn...
Data of 130 VO patients (SA=95; ENST=35) were available at T1. Treatment failure occurred in 37% of SA patients and 23% of ENST patients. On multivariate analysis SA [odds ratio (OR): 3.12; 95% confid...
In our cohort every third patient with VO caused by SA or ENST dies within 1 year. Our findings indicate that patients with VO caused by SA, concomitant IE and/or a high Charlson comorbidity index sco...